A Study of Pyrotinib Versus Docetaxel in Patients With Advanced Lung Cancer
Non-squamous NSCLC HER2 Exon 20 Mutation pyrotinib docetaxel NSCLC Carcinoma, Non-Small-Cell Lung
Lead Scientist at UC Davis
- Tianhong Li
Associate Professor, Hematology and Oncology. Authored (or co-authored) 65 research publications.